載入...
Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma
<p>Abstract</p> <p>Background</p> <p>Despite all benefit provided by established therapies prognosis of gastric cancer remains poor. Targeted inhibition of platelet derived growth factor receptor (PDGFR) by imatinib may influence tumor growth and amplify chemotherapeuti...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMC
2012-12-01
|
| 叢編: | BMC Cancer |
| 主題: | |
| 在線閱讀: | http://www.biomedcentral.com/1471-2407/12/587 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|